Navigation Links
Clinilabs Launches Research Volunteer Authentication Initiative Choosing Verified Clinical Trials to Stop Dual Enrollment in Clinical Trials
Date:4/2/2013

New York, NY (PRWEB) April 02, 2013

Clinilabs, an early phase and specialty CRO that provides clinical drug development services to industry, today announced that it has launched a subject authentication initiative at its Phase 1 sites in New York and New Jersey. This initiative includes the authentication of subject identity and medical history, background checks, and tracking of prior study participation in order to eliminate ineligible subjects from clinical trials. The Company has selected Verified Clinical Trials (VCT) to assist with this initiative, implementing the VCT clinical trials database registry system. VCT’s registry is designed to stop the professional research subjec t from enrolling in multiple clinical trials simultaneously – a situation known as dual enrollment. This collaboration between Clinilabs and VCT is a reflection of both companies’ commitment to volunteer safety and data quality.

Failure to document the identity of study volunteers, inaccuracies in subjects’ medical histories, and multiple concurrent enrollments have become a serious problem in the clinical research world. Study volunteers interested in free care or compensation may present inaccurate information in order to gain entry to clinical trials, and some may jump from one study to another without waiting for enough time to lapse between treatments. This type of research volunteer places everyone at risk including the drug manufacturer, the research site, and most importantly, themselves, potentially jeopardizing their health. Furthermore, this may compromise data quality.

'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Seahorse Bioscience Launches First Product from the Partnership with Baystate Medical Center and UMass Amherst
2. Neighborhood Smiles Launches a Groundbreaking Cavity Prevention Program for Their Patients
3. Dr. Timothy Rauch of Albuquerque, New Mexico Launches a Groundbreaking Cavity Prevention Program
4. CellHealth Institute Launches with Support from Influential Investors
5. Dr. Richard Charmoy Launches Groundbreaking Cavity Prevention Program that Can Lower Tooth Decay Rates by 74%
6. Elsevier Launches Web-Based Pathway Studio and Adds New Molecular Data from Its Biology Journals to Boost Early Discovery Research
7. BioHealth Innovation, Inc. Launches Program to Help Life Science Companies Navigate Federal Funding Application Process
8. Rockingham County Economic Development Launches New Website
9. Neogen launches rapid tests for ractopamine
10. Elsevier Launches PracticeUpdate, a Free Information Portal for Physicians
11. Guidepoint Global Launches Two Major Enhancements to its Client Research Portal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... DUBLIN , Sept. 18, 2014 ... the "Global Companion Diagnostics (Polymerase Chain Reaction, In-situ ... report to their offering. The ... a CAGR of 22.7% from 2014 to 2019. Factors ... treatment, growing adoption of companion diagnostics by the pharmaceutical ...
(Date:9/18/2014)... -- U.S. biotech company Kultevat has strengthened its ... developed by the Donald Danforth Plant Science Center ... applications in production of natural rubber in Taraxicum ... under the direction of Roger Beachy , Ph.D., ... the Danforth Plant Science Center, and is used to ...
(Date:9/18/2014)... Sept. 18, 2014  Neogen Corporation (Nasdaq: ... a strategic agreement with Merck Animal Health to market ... The Igenity Dairy Heifer Program consists of genomic ... the genetic potential of replacement dairy heifers. The genomic ... born, and is an excellent tool in the decision-making ...
(Date:9/18/2014)... Pennsylvanie, 18 septembre 2014 Mapi, ... en 1974, a été depuis 40 ans ... évaluations cliniques traditionnelles par des évaluations recentrées ... sur les impacts économiques des traitements. ... A cours d,une récente conférence ...
Breaking Biology Technology:Global Companion Diagnostics (Polymerase Chain Reaction, In-situ hybridization, Immunohistochemistry) Market - Trends & Forecasts to 2019 2Global Companion Diagnostics (Polymerase Chain Reaction, In-situ hybridization, Immunohistochemistry) Market - Trends & Forecasts to 2019 3Kultevat obtains license of gene switch technology 2Merck Animal Health to market Neogen's dairy genomic program 21974 - 2014 - Mapi fête ses 40 ans 2
... 7 Amsterdam Molecular,Therapeutics (Euronext: AMT), a leader ... the treatment of the first patient in a ... targets,lipoprotein lipase deficiency (LPLD), a seriously debilitating and,potentially ... randomized controlled trial has been designed to gather ...
... Kendle (Nasdaq: KNDL ), a leading, global ... or $0.06 per share for the first quarter 2009 compared ... share for the first quarter 2008. On a pro forma ... $0.47 per diluted share compared with $0.38 per diluted share ...
... Amgen (Nasdaq: AMGN ), today announced ... Stockholders, held at The St. Regis Hotel, San Francisco, ... represented at the meeting.The director nominees: David Baltimore, Frank ... Vance D. Coffman, Frederick W. Gluck, Frank C. Herringer, ...
Cached Biology Technology:AMT Starts Preregistration Trial for Glybera(TM) 2AMT Starts Preregistration Trial for Glybera(TM) 3Kendle Announces First Quarter 2009 Results 2Kendle Announces First Quarter 2009 Results 3Kendle Announces First Quarter 2009 Results 4Kendle Announces First Quarter 2009 Results 5Kendle Announces First Quarter 2009 Results 6Kendle Announces First Quarter 2009 Results 7Kendle Announces First Quarter 2009 Results 8Amgen Announces Voting Results Of Annual Meeting Of Stockholders 2
(Date:9/19/2014)... A new study shows that legume plants regulate ... cytokininssignaling molecules that are transmitted through the plant ... the number of bacteria-holding nodules in the roots. ... the National Institute for Basic Biology, the Graduate ... Center for Sustainable Resource Science in Japan. ...
(Date:9/18/2014)... A sleep-promoting circuit located deep in the primitive brainstem ... by researchers at Harvard School of Medicine and the ... this is only the second "sleep node" identified in ... necessary and sufficient to produce deep sleep. , Published ... study demonstrates that fully half of all of the ...
(Date:9/18/2014)... robotic system that can operate inside the bore of ... of a biomedical research partnership program at Brigham and ... if the robot, in conjunction with real-time MRI images, ... costly, and less discomforting for the patient. The novel ... therapies with greater precision. , Developed by a team ...
Breaking Biology News(10 mins):For legume plants, a new route from shoot to root 2No sedative necessary: Scientists discover new 'sleep node' in the brain 2Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 2Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 3Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 4Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 5
... harnessing of 'T-rays' - electromagnetic terahertz waves - which ... varied as biological cell abnormalities and explosives has been announced. ... in Spain have said they have found a way to ... Their findings are set out in a letter published in ...
... heart is removed, the dynamic interplay between a mass ... the protective cell layer that covers the wound spurs ... Medical Center scientists have found. , The scientists further ... the cell mass and the protective covering, encouraging the ...
... Institute of Virology and Immunology (GIVI) have identified a previously ... HIV, a finding that may lead to new approaches for ... Oct. 2, 2006, in Proceedings of the National Academy of ... laboratory of GIVI Director Warner C. Greene, MD, PhD, explains ...
Cached Biology News:T-ray breakthrough could make detecting disease far easier 2Key to zebrafish heart regeneration uncovered 2Key to zebrafish heart regeneration uncovered 3Gladstone investigators identify a new protective action for the powerful anti-HIV factor, APOBEC3G 2
Mouse polyclonal antibody to ALS2CR8 - amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 8...
...
Mouse monoclonal [CAT-2] to Chloramphenicol Acetyltransferase...
Recommended fro Western blotting application...
Biology Products: